© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
September 08, 2021
TearClear to start clinical trial for TC-002 latanoprost ophthalmic solution 0.005%.
July 13, 2021
New strategies are needed to rethink how we treat glaucoma to do more than just manage eye pressure—to actually restore vision by promoting the survival of retinal ganglion cells and their axons.
July 12, 2021
There’s no shortage of diet programs—Paleo, Mediterranean, intermittent fasting—all claiming to be the best option for a healthy life. Research has shown that poor lifestyle choices, including unhealthy diets, contribute to many diseases and that simply adhering to good nutrition can even prevent some health issues.
June 07, 2021
According to preliminary results, intranasally delivered ST266 is a safe treatment option.
April 19, 2021
George Waring IV, MD serves as guest host for ‘History and Evolution of Contemporary Refractive Surgery’
March 23, 2021
A clinical trial of NCX 470 will evaluate the drug for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.
February 17, 2021
New World Medical relied on feedback from surgeons in the development of the device, which was registered with the FDA in October.
July 30, 2020
How gonioscopy can offer ophthalmologists an option in treating patients with glaucoma
July 29, 2020
Researchers must weigh emotional, financial, and reputational considerations
July 28, 2020
Trabeculectomy may offer better results with more severe glaucoma
